查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1801047

感染控制市场报告（按类型（设备、服务、消耗品）、最终用户（医院和诊所、医疗器材公司、临床实验室、製药公司等）和地区）2025 年至 2033 年

Infection Control Market Report by Type (Equipment, Services, Consumables), End User (Hospitals and Clinics, Medical Device Companies, Clinical Laboratories, Pharmaceutical Companies, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球感染控制市场规模达281亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到497亿美元，2025-2033年期间的复合年增长率（CAGR）为6.22%。北美凭藉其强大的医疗基础设施和灭菌消毒技术的广泛应用，占据了市场主导地位。此外，诊断和感染控制设备的技术快速进步、兽医和动物护理环境需求的不断增长、传染病预防研发的不断加强以及对预防医院相关感染（HAI）的日益重视，都是推动市场成长的一些因素。

公众和医疗机构的卫生安全意识正在显着提升。医疗服务提供者强调消毒和卫生，以避免交叉污染。这种意识也传递给患者，促使医疗机构在感染控制方面投入更多资源。对更安全环境的追求不断推动着产业对更先进产品和规程的需求。此外，消毒工具和用品的不断进步也提高了它们的功效和使用者友善性。如今，自动化灭菌系统、增强型化学製剂和即时监控工具都已唾手可得。这些创新技术在提高医疗效果的同时，也降低了人力成本和长期成本，使其成为当代医疗营运中极具吸引力的投资。此外，择期手术和急诊手术的增加也带来了对无菌环境的更大需求。手术室需要严格的感染控制措施，涉及各种用品和器械。随着手术量的增加，统一的感染控制需求也日益增长，使其成为医疗机构关注的重点领域。

感染控制市场趋势：

老年人口不断增加

全球老年人口显着成长，这对感染控制市场的发展至关重要。世界卫生组织 (WHO) 预测，到 2030 年，全球六分之一的人口将年龄在 60 岁及以上，预计全球老年人口将从 2020 年的 10 亿增加到 2030 年的约 14 亿。到 2050 年，这一数字预计将达到 21 亿左右。人口结构的这种变化直接影响医疗保健系统，因为老年人的免疫反应通常较弱，更容易受到感染。因此，医院、疗养院和长期照护机构对严格感染控制措施的需求日益增长。坚持严格的卫生标准和实施先进的消毒方法对于管理这一年龄层的人至关重要。这些因素进一步对感染控制市场预测产生了正面影响。

医院相关感染（HAI）盛行率上升

在医院及不同区域临床环境中，医院相关感染 (HAI) 的发生率日益上升，已成为一个重要议题，这极大地推动了对高效感染控制策略的需求。常见的 HAI 类型，包括手术部位感染、导管相关感染和呼吸器相关性肺炎，对患者的健康构成重大威胁，并导致住院时间延长、医疗费用上升和发病率上升。欧洲疾病预防控制中心的报告显示，欧盟/欧洲经济区每年有近 430 万名住院患者至少感染一次 HAI。这项令人担忧的统计数据凸显了改善感染预防措施和采用先进消毒灭菌技术的迫切必要性。医疗保健提供者正在逐步将资源投入到感染控制产品中，以确保患者安全并遵守严格的监管要求。对降低感染率的日益重视正在促进感染控制行业的发展。

不断扩张的门诊服务业

日益转向门诊服务正成为推动感染控制产品和技术需求的主要因素。这些门诊护理中心提供医疗服务而无需住院过夜，因其便利性、可负担性和可近性而越来越受欢迎。根据IMARC Group报道，全球门诊服务市场在 2023 年的估值达到 3.8 兆美元，预计到 2032 年将扩大到 6.3 兆美元，2024 年至 2032 年的年复合成长率(CAGR) 为 5.7%。由于这种扩展，在门诊接受护理的患者数量正在增加，这增加了对严格感染控制措施的需求。由于患者流动率高、治疗週期短以及避免交叉污染的必要性，这些设施需要可靠的灭菌、表面消毒和个人防护措施。预计对门诊安全和法规遵守的日益重视将提高感染控制市场的收入。

感染控制市场成长动力：

技术进步与产品创新

消毒和灭菌技术的进步正在彻底改变感染控制市场，提高其精确度、效率以及与不断变化的临床需求的兼容性。材料、自动化系统、化学物质和监控平台的进步正在提升感染控制的可靠性和安全性。一个突出的例子是2024年推出的Getinge Poladus 150，这是一款专为热敏性手术器械设计的低温VH2O2灭菌器。它采用了尖端的交叉污染预防技术​​，旨在最大限度地减少医疗相关感染，同时优化无菌供应单元的流程。该系统还与数位平台连接，提高了医院再处理过程中的可追溯性和运作效率。这些创新使医护人员能够更均匀地执行灭菌程序，并减少错误。对自动化、可追溯系统和直觉式介面的关注正在最大限度地减少繁重的劳动，并增强对法规的遵守。随着医疗服务提供者对这些技术的成本和安全优势的认识不断提高，它们的应用正在加速。

公共卫生运动和政府倡议

政府主导的公共卫生宣传活动和政策措施对于加强感染控制措施至关重要。这些措施能够提高公众卫生意识，鼓励负责任地使用抗菌药物，并倡导临床和社区环境中的最佳实践。管理机构经常分配资源，用于加强公立医院的感染控制系统，提供依从性激励措施，并支持追踪感染模式的监测措施。国家医疗保健策略正逐步将感染预防作为一项重要目标，确保各机构与更广泛的卫生目标保持一致。针对医护人员和一般民众的教育推广活动，强化了有助于降低传播风险的行为改变。这些宣传活动也增加了对消毒剂、灭菌设备和防护装备等标准化物品的需求。这些倡议在增强公共安全的同时，也产生了持续的需求，尤其是在意识和基础设施仍在发展中的发展中地区。

产业合作

医疗器材製造商与医疗保健利害关係人之间的合作对于促进感染控制市场的扩张至关重要。这些合作有助于提升大众对尖端科技的认知、教育和普及，从而解决关键的医疗保健问题，尤其是在感染预防方面。近期的一个例子是Bactiguard和BD在印度CRITICARE 2025上的合作，双方强调了应对医院相关感染（HAI）和抗菌素抗药性（AMR）的重要性，尤其是在重症监护环境中。在整个活动期间，临床会议强调了Bactiguard涂层导管在降低导管相关泌尿道感染（CAUTI）和促进合理使用抗生素方面的优势。 BD也透露，这些尖端设备即将在印度市场上市。这些措施不仅将先进技术引入需求旺盛的地区，也强化了产业合作在推动全球感染控制目标、提高病患安全性和拓宽市场进入的重要性。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球感染控制市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 装置
    • 主要类型
      • 消毒器
        • 垫圈
        • 冲洗器
        • 超音波清洗机
      • 灭菌设备
        • 热灭菌
        • 低温灭菌
        • 辐射灭菌
        • 基于过滤的灭菌
      • 其他的
  • 服务
    • 主要类型
      • 合约灭菌
        • 环氧乙烷灭菌
        • 伽玛射线灭菌
        • 电子束灭菌
        • 蒸气灭菌
      • 传染性废弃物处理
  • 耗材
    • 主要类型
      • 消毒剂
      • 灭菌耗材
      • 个人防护装备
      • 其他的

第七章：市场区隔：依最终用户

  • 医院和诊所
  • 医疗器材公司
  • 临床实验室
  • 製药公司
  • 其他的

第八章：市场区隔：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第九章：SWOT分析

第 10 章：价值链分析

第 11 章：波特五力分析

第 12 章：价格分析

第 13 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 3M Company
    • Advanced Sterlization Products Services Inc. (Fortive Corporation)
    • Belimed AG (Metall Zug)
    • Cantel Medical Corp.
    • Getinge AB
    • Matachana
    • Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc)
    • MMM Munchener Medizin Mechanik GmbH
    • Pal International
    • Sterigenics US LLC (Sotera Health Holdings LLC)
    • Steris Corporation
    • TSO3 Inc. (Stryker Corporation)
Product Code: SR112025A2509

The global infection control market size reached USD 28.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033. North America dominates the market because of robust healthcare infrastructure and widespread adoption of sterilization and disinfection technologies. Moreover, the rapid technological advancements in diagnostic and infection control equipment, the increasing demand in veterinary and animal care settings, rising R&D in infectious disease prevention, and the growing focus on preventing healthcare-associated infections (HAIs) are some of the factors propelling the market growth.

Awareness about hygiene and safety among the public and institutions is rising considerably. Healthcare providers emphasize sterilization and hygiene to avoid cross-contamination. This consciousness spreads to patients, motivating institutions to allocate more resources to infection control. The drive for safer surroundings is consistently driving the need for enhanced products and protocols in the industry. Furthermore, ongoing advancements in disinfection tools and supplies are enhancing both their efficacy and user-friendliness. Automated sterilization systems, enhanced chemical formulations, and real-time monitoring tools are now easily available. These innovations improve results while lowering labor and long-term expenses, making them appealing investments for contemporary healthcare operations. Besides this, the increase in elective and emergency surgeries results in a greater need for sterile environments. Surgical suites necessitate rigorous infection control measures, involving a wide array of supplies and instruments. With the rise in surgical volumes, the necessity for uniform infection control grows, making it a key area of focus for healthcare institutions.

Infection Control Market Trends:

Increasing Geriatric Population

There has been a notable rise in the global geriatric population, which plays a crucial role in shaping the infection control market. As projected by the World Health Organization (WHO), by the year 2030, one in six people globally will be aged 60 and above, with the worldwide senior population anticipated to rise from 1 billion in 2020 to approximately 1.4 billion by 2030. By the year 2050, this figure is expected to be around 2.1 billion. This change in demographics directly affects healthcare systems, as older individuals commonly exhibit weaker immune responses and increased vulnerability to infections. As a result, the need for strict infection control measures in hospitals, nursing homes, and long-term care facilities is growing consistently. Upholding rigorous hygiene standards and implementing cutting-edge sterilization methods are crucial in managing this age demographic. These factors further positively influence the infection control market forecast.

Rising Prevalence of Healthcare-Associated Infections (HAI)

The growing frequency of healthcare-associated infections (HAIs) in hospitals and clinical environments in different areas is emerging as a significant issue, considerably driving the need for efficient infection control strategies. Frequent forms of HAIs, including surgical site infections, catheter-related infections, and ventilator-related pneumonia, represent significant health dangers to patients and lead to prolonged hospitalizations, rising healthcare costs, and elevated morbidity rates. A publication from the European Centre for Disease Prevention and Control indicates that nearly 4.3 million hospital patients in the EU/EEA acquire at least one HAI each year. This concerning statistic highlights the critical necessity for improved infection prevention measures and the implementation of cutting-edge disinfection and sterilization technologies. Healthcare providers are progressively allocating resources to infection control products to guarantee patient safety and adhere to rigorous regulatory requirements. The increasing focus on lowering infection rates is strengthening the growth of the infection control industry.

Expanding Ambulatory Services Industry

The increasing transition towards outpatient services is becoming a major factor in driving the demand for infection control products and technologies. These outpatient care centers, providing medical services without the need for overnight hospital admissions, are becoming more popular because of their convenience, affordability, and accessibility. As reported by IMARC Group, the worldwide ambulatory services market attained a valuation of US$ 3.8 Trillion in 2023 and is expected to expand to US$ 6.3 Trillion by 2032, with a compound annual growth rate (CAGR) of 5.7% from 2024 to 2032. As a result of this expansion, the number of patients receiving care in outpatient settings is increasing, which heightens the need for strict infection control measures. Due to high patient turnover, swift treatment cycles, and the necessity to avert cross-contamination, these facilities demand dependable sterilization, surface disinfection, and personal protective measures. The rising emphasis on safety and regulatory adherence in outpatient settings is anticipated to boost the infection control market revenue.

Infection Control Market Growth Drivers:

Technological Advancement and Product Innovation

Advancements in technology for disinfection and sterilization are transformed the infection control market, enhancing its precision, efficiency, and compatibility with changing clinical needs. Advancements in materials, automated systems, chemical substances, and monitoring platforms are enhancing reliability and safety in infection control. A prominent instance is the 2024 introduction of Getinge's Poladus 150, a low-temperature VH2O2 sterilizer designed specifically for heat-sensitive surgical tools. It featured cutting-edge cross-contamination prevention technology designed to minimize healthcare-related infections while optimizing processes in sterile supply units. The system also connected with digital platforms, providing improved traceability and operational effectiveness during hospital reprocessing. Such innovations enable healthcare personnel to execute sterilization procedures with improved uniformity and reduced mistakes. The focus on automation, traceable systems, and intuitive interfaces is minimizing labor-heavy tasks and enhanced adherence to regulations. With increasing awareness among healthcare providers regarding the cost and safety advantages of these technologies, their adoption is accelerating.

Public Health Campaigns and Government Initiatives

Public health campaigns and policy initiatives led by the government are vital in enhancing infection control measures. These initiatives enhance awareness about hygiene, encourage responsible use of antimicrobials, and advocate for best practices in clinical and community environments. Governing bodies frequently assign resources to enhance infection control systems in public hospitals, provide incentives for adherence, and back surveillance initiatives that track infection patterns. National healthcare strategies are progressively prioritizing infection prevention as a key goal, making sure that institutions align with wider health objectives. Educational outreach aimed at both healthcare professionals and the general public reinforces behavior modifications that help lower transmission risks. These campaigns also increase the demand for standardized items, such as disinfectants, sterilization devices, and protective gear. These initiatives enhance public safety while generating ongoing demand, especially in developing areas where awareness and infrastructure are still growing.

Industry Collaboration

Collaborative efforts between manufacturers of medical devices and healthcare stakeholders are essential in promoting the expansion of the infection control market. These collaborations promote awareness, education, and availability of cutting-edge technologies that tackle critical healthcare issues, especially in preventing infections. A recent instance is the collaborative effort by Bactiguard and BD at CRITICARE 2025 in India, where both organizations highlighted the significance of addressing healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), especially in intensive care settings. Throughout the event, clinical sessions emphasized the advantages of Bactiguard-coated catheters in decreasing catheter-associated urinary tract infections (CAUTI) and promoting responsible antibiotic usage. BD has also revealed the imminent release of these cutting-edge devices in the Indian market. These initiatives not only introduce advanced technologies to areas with significant needs but also strengthen the importance of industry partnerships in promoting worldwide infection control objectives, improving patient safety, and broadening market access.

Global Infection Control Industry Segmentation:

Breakup by Type:

  • Equipment
    • Disinfectors
    • Washers
    • Flushers
    • Ultrasonic Cleaners
    • Sterilization Equipment
    • Heat Sterilization
    • Low Temperature Sterilization
    • Radiation Sterilization
    • Filtration-Based Sterilization
    • Others
  • Services
    • Contract Sterilization
    • ETO Sterilization
    • Gamma Sterilization
    • E-Beam Sterilization
    • Steam Sterilization
    • Infectious Waste Disposal
  • Consumables
    • Disinfectants
    • Sterilization Consumables
    • Personal Protective Equipment
    • Others

Consumables dominate the market

According to the infection control market outlook, the consumables segment, including disinfectants, sterilization consumables, personal protective equipment (PPE), and other related products, is the largest market segment in the industry. These consumables play a critical role in preventing and controlling the spread of infections across various sectors, such as healthcare, food processing, and public spaces. Disinfectants are vital in healthcare facilities, laboratories, and public spaces to eliminate harmful pathogens on surfaces and minimize the risk of infections. Sterilization consumables, like autoclave bags and indicator tapes, are indispensable in maintaining sterile medical instruments and equipment conditions.

Breakup by End User:

  • Hospitals and Clinics
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Companies
  • Others

Hospitals and clinics dominate the market

According to the infection control market overview, the hospitals and clinics segment emerged as the largest market share holder in the industry, reflecting the critical role of infection prevention measures in healthcare settings. Hospitals and clinics are high-risk environments where vulnerable patients, healthcare professionals, and visitors come into close contact, making them susceptible to infectious diseases. Infection control is of utmost importance in these settings to curb the spread of healthcare-associated infections (HAIs) and safeguard patient safety. Strict protocols, including hand hygiene, sterilization of medical equipment, and the use of personal protective equipment (PPE), are integral to maintaining a safe and sterile environment. Besides this, with a growing focus on patient care, hospital accreditation, and regulatory compliance, the demand for these solutions in hospitals and clinics remains robust. As healthcare facilities strive to enhance infection prevention measures and reduce the burden of HAIs, the hospitals and clinics segment is expected to continue leading the market.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest infection control market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Russia, and Others); Europe (Germany, France, the United Kingdom, Italy, Spain, and Others); Latin America (Brazil, Mexico, and Others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

According to the infection control market statistics, North America, comprising the United States and Canada, dominate the market, which can be attributed to several key factors driving its growth. The region's significant aging population contributes to the rising demand for infection control measures. For instance, according to an article published by the Population Reference Bureau, the number of people in the United States aged 65 and older is expected to rise from 58 million in 2022 to 82 million by 2050 (a 47% increase), with the 65-and-over age group accounting for 17% to 23% of the overall population. Moreover, the region's technologically advanced healthcare infrastructure fosters the adoption of innovative infection control solutions, including advanced disinfectants, sterilization technologies, and smart medical devices.

Competitive Landscape:

Top companies catalyze the market by introducing innovative solutions and technologies to combat infectious diseases. These companies invest heavily in research and development, creating cutting-edge disinfection and sterilization products that effectively prevent the spread of infections. Their commitment to maintaining stringent quality standards and adherence to regulatory guidelines instills trust among healthcare providers, bolstering their market presence. Moreover, these companies actively engage in educational programs and awareness campaigns, emphasizing the importance of infection prevention and control measures. Continued efforts to expand their global footprint through strategic collaborations and acquisitions further fuel market growth. They address environmental concerns and attract environmentally-conscious consumers by prioritizing sustainability and eco-friendly practices.

The infection control market research report has provided a comprehensive analysis of the competitive landscape in the infection control market. Detailed profiles of all major companies have also been provided.

  • 3M Company
  • Advanced Sterlization Products Services Inc. (Fortive Corporation)
  • Belimed AG (Metall Zug)
  • Cantel Medical Corp.
  • Getinge AB
  • Matachana
  • Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
  • MMM Munchener Medizin Mechanik GmbH
  • Pal International
  • Sterigenics U.S. LLC (Sotera Health Holdings LLC)
  • Steris Corporation
  • TSO3 Inc. (Stryker Corporation)

Key Questions Answered in This Report:

  • How has the global infection control market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global infection control market?
  • What is the impact of each driver, restraint, and opportunity on the global infection control market?
  • What are the key regional markets?
  • Which countries represent the most attractive infection control market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the global infection control market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global infection control market?
  • What is the competitive structure of the global infection control market?
  • Who are the key players/companies in the global infection control market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Infection Control Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Disinfectors
        • 6.1.2.1.1 Washers
        • 6.1.2.1.2 Flushers
        • 6.1.2.1.3 Ultrasonic Cleaners
      • 6.1.2.2 Sterilization Equipment
        • 6.1.2.2.1 Heat Sterilization
        • 6.1.2.2.2 Low Temperature Sterilization
        • 6.1.2.2.3 Radiation Sterilization
        • 6.1.2.2.4 Filtration-Based Sterilization
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Contract Sterilization
        • 6.2.2.1.1 ETO Sterilization
        • 6.2.2.1.2 Gamma Sterilization
        • 6.2.2.1.3 E-Beam Sterilization
        • 6.2.2.1.4 Steam Sterilization
      • 6.2.2.2 Infectious Waste Disposal
    • 6.2.3 Market Forecast
  • 6.3 Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 Disinfectants
      • 6.3.2.2 Sterilization Consumables
      • 6.3.2.3 Personal Protective Equipment
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast

7 Market Breakup by End User

  • 7.1 Hospitals and Clinics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Device Companies
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Clinical Laboratories
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pharmaceutical Companies
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 3M Company
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Advanced Sterlization Products Services Inc. (Fortive Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Belimed AG (Metall Zug)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
    • 13.3.4 Cantel Medical Corp.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Getinge AB
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Matachana
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc)
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 MMM Munchener Medizin Mechanik GmbH
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
    • 13.3.9 Pal International
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
    • 13.3.10 Sterigenics U.S. LLC (Sotera Health Holdings LLC)
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
    • 13.3.11 Steris Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 TSO3 Inc. (Stryker Corporation)
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Infection Control Market: Major Drivers and Challenges
  • Figure 2: Global: Infection Control Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Infection Control Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Infection Control Market: Breakup by End User (in %), 2024
  • Figure 5: Global: Infection Control Market: Breakup by Region (in %), 2024
  • Figure 6: Global: Infection Control Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 7: Global: Infection Control (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 8: Global: Infection Control (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 9: Global: Infection Control (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Infection Control (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Infection Control (Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Infection Control (Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Infection Control (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Infection Control (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Infection Control (Medical Device Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Infection Control (Medical Device Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Infection Control (Clinical Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Infection Control (Clinical Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Infection Control (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Infection Control (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Infection Control (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Infection Control (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: North America: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: North America: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: United States: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: United States: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Canada: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Canada: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Asia Pacific: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Asia Pacific: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: China: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Japan: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Japan: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: India: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: India: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: South Korea: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: South Korea: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Australia: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Australia: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Indonesia: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Indonesia: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Others: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Europe: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Europe: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Germany: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Germany: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: France: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: France: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United Kingdom: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United Kingdom: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Italy: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Italy: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Spain: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Spain: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Russia: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Russia: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Others: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Latin America: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Latin America: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Brazil: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Brazil: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Mexico: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Mexico: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Middle East and Africa: Infection Control Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Middle East and Africa: Infection Control Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Global: Infection Control Industry: SWOT Analysis
  • Figure 72: Global: Infection Control Industry: Value Chain Analysis
  • Figure 73: Global: Infection Control Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Infection Control Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Infection Control Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Infection Control Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 4: Global: Infection Control Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 5: Global: Infection Control Market: Competitive Structure
  • Table 6: Global: Infection Control Market: Key Players